The Analysis of Knowledge, Adherence, and Clinical Outcome of Hypertensive Patients in Puskesmas Jetis Yogyakarta
DOI:
https://doi.org/10.35814/jifi.v21i1.1100Keywords:
Adherence, clinical outcome, hypertension, knowledge, puskesmas JetisAbstract
Hypertension has been an increasing global epidemic problem over years and considered as one of the deadly disease with a high cardiovascular complication risk. Knowledge and adherence play an important role in patient's clinical impact, which determined the level of medication’s adherence. Thus, adherence level determines the achievement of clinical outcome. The optimum clinical optimum will be achieved if the adherence level is at good level. The method in this study was using observational analytics with a cross sectional approach. The sampling method was consecutive sampling. The subjects were the adult hypertensive patients at Puskesmas Jetis Kota from August until October 2020. Univariate analysis was conducted in patient’s and medication characteristics. Kendal Tau test was used to analyze the relationship between adherence and clinical outcome. 81 hypertensive patients were included in this study. The highest prevalence of patient’s characteristics were shown on the women’s group: 45-59 years old, senior high school education background, and no occupation. Amlodipine was the highest medication used as a single therapy. It was found that there is no relationship between knowledge and adherence level. In addition to that, there was no relationship between adherence level and clinical outcome measured by systole and diastole.
References
Downloads
Published
Issue
Section
License
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

















